Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Citycon Oyj: Managers’ Transactions

CITYCON OYJ   Managers’ Transactions   15 December 2020 at 10:45 hrsThe acquisition of shares (in total 21,600) is based on the vesting period of 16 November 2019 to 15 November 2020 in the CEO Restricted Share Plan 2018‒2021. Person subject to the notification requirement: F. Scott Ball, CEOIssuer: Citycon Oyj, LEI 549300P8N0P6KDGTJ206Notification type: initial notificationReference number: 549300P8N0P6KDGTJ206_20201215091701_21) TransactionDate: 11 December 2020Venue: NASDAQ HELSINKI LTD (XHEL)Nature of the transaction: acquisitionInstrumentshare (CTY1S)ISIN Code:

Data showing high implant survival rate for Episealer® accepted for publication

Episurf Medical (Nasdaq: EPIS B) today announces that post-market surveillance survival data for the Episealer® Knee implant has been compiled and accepted for scientific publication in the peer-reviewed journal Surgical Technology International. The data shows a cumulative survival rate of >96% over 7 years. The publication, Patient-specific implants for focal cartilage lesions in the knee: implant survivorship analysis up to seven years post-implantation, by L. Ryd, K. Flodström and M. T. Manley focuses on survival data for 682 Episealer® knee implants implanted between 2012 and 2020. "

Risk Intelligence A/S records 0% churn and increases in license sizes in Q4 2020

Risk Intelligence A/S (“Risk Intelligence” or "the Company") announces 0% churn (100% renewal) as well as increases in license sizes and additional sales to existing clients in Q4 2020.Q4 is Risk Intelligence’s major annual renewal period for Risk Intelligence System licenses due to the large part of licenses that follow the calendar year, generating a strong base of recurring revenue for 2021. This year in Q4, 100% of Risk Intelligence System clients have renewed their licences, with several increasing the scope of the licence by adding more users or additional subscriptions to the

Correction: Metso Outotec's financial reporting in 2021

Metso Outotec Corporation’s stock exchange release on December 15, 2020, at 10:30 a.m. EETThis release replaces the stock exchange release published by Metso Outotec on December 14, at 9:00 a.m. EET, which included a wrong date for the publishing of the Financial Statements for 2020.Metso Outotec’s corrected dates for its financial reporting in 2021 are as follows.  · Financial Statements Review for 2020 on February 16, 2021 · Interim Report for January - March 2021 on April 23, 2021 · Half-Year Financial Report for January - June 2021 on August 4, 2021 · Interim Report

DOF ASA AND DOF SUBSEA AS: EXTENSION OF STANDSTILL ARRANGEMENT WITH BONDHOLDERS

Reference is made to the bondholders' meeting in DOFSUB07 (ISIN NO 001 0670144), DOFSUB08 (ISIN NO 001 078817.7) and DOFSUB09 (ISIN NO 001 083681.0) held on 30 September 2020 in accordance with the summons dated 16 September 2020, as amended by the addendum to the summons dated 30 September 2020. DOF Subsea AS has today received confirmation from the ad hoc group of bondholders that they have agreed to extend the suspension, deferral and standstill arrangement currently in place for the bond issue from 15 December 2020 to 31 January 2021 in accordance with the resolutions made at the

Cyxone has filed an IND in the US with Rabeximod following positive feed-back from pre-IND meeting with the FDA

Cyxone (publ.), a clinical stage biotech company developing first-in-class drugs for diseases of the immune system, announced today that the company has filed an Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) pertaining to its drug candidate Rabeximod. The application follows on a productive pre-IND meeting with the authority, where valuable advice was received on inter alia the protocol for its imminent European Phase 2 clinical study in moderate Covid-19. The IND covers the development of Rabeximod in Covid-19 and other indications, such as

DOCOMO Digital study reveals that the Covid-19 pandemic has accelerated the adoption of carrier billing

More than half of merchants consider working with a Direct Carrier Billing Specialist in 2021London, December 15, 2020 – A new study commissioned and sponsored by DOCOMO Digital, a global leader in direct carrier billing and alternative payments, reveals that the Covid-19 pandemic expedited the shift to carrier billing across global markets, with the majority of mobile operators surveyed identifying significant market opportunities to expand into new areas, some of which are not served by traditional payment methods. The study finds that approximately half of the respondents have or plan to

Changes and extensions to Relais Group Plc’s Facilities Agreement

Relais Group Plc Company Release 15.12. 2020 at 10.05 Changes and extensions to Relais Group Plc’s Facilities Agreement Relais Group Plc has agreed on extensions and amendments of its Facilities Agreement originally concluded in 2019 with its main bank. The Amended and Restated Facilities Agreement includes the refinancing of existing financing for corporate acquisitions and a new term loan facility of EUR 40 million for possible future corporate acquisitions. The Amended and Restated Facilities Agreement will remain in force until the end of May 2023. The maximum amount of

Half of Brits opt out of turkey this Christmas: sustainable food, relaxation and gifts with purpose on the menu this year

Kimberly Wyatt’s tips for a sustainable & stress-less ChristmasDespite the announcement of restrictions lifting over the festive period, over a third of us have decided to say goodbye to an indulgent Christmas and opt for a low-key, at home celebration, with relaxation, reading, family favourite foods and sustainable gifts top priority.One in four people are looking forward to not travelling anywhere for Christmas this year, with one in five planning a virtual gathering and a third of us avoiding the pre- Christmas crowds altogether by doing all their shopping online.The

Massive increase in testing capacity and pride of workmanship – the new Nokian Heavy Tyres R&D Center is up and running

Making professional tire use safer and more efficient sets high demands on product development. To bring new ideas to the market faster, testing has an important role. Nokian Tyres has invested heavily on a new, state-of-the-art test center for Nokian Heavy Tyres, upgrading the testing capabilities to a whole new level with added automation and capacity. Despite the challenges caused by the COVID-19 outbreak, the magic is already happening in the new building – enabling us to introduce more and better new heavy tires.   Due to Covid-19 restrictions, many phases of the construction

Lehto Group Plc: Managers’ Transactions

Lehto Group PlcManagers’ Transactions15 December 2020 at 10.00 (EET)Lehto Group Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Lehto, Hannu Position: Chief Executive Officer Issuer: Lehto Group Oyj LEI: 743700YEHY9I3ZDHNX66 Notification type: INITIAL NOTIFICATION Reference number: 743700YEHY9I3ZDHNX66_20201215094330_3 ____________________________________________ Transaction date: 2020-12-01 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: FINANCIAL INSTRUMENT LINKED TO A

Financial Calendar for Panoro Energy ASA

FINANCIAL YEAR 2020 30.04.2021 – Annual Report 25.02.2021 – Quarterly Report – Q4   FINANCIAL YEAR 2021 25.08.2021 – Half-yearly Report27.05.2021 – Annual General Meeting 27.05.2021 – Quarterly Report – Q122.11.2021 – Quarterly Report – Q3   The Company holds a webcast presentation each quarter to discuss the results and operations. Event details are announced ahead of each quarterly results announcement. The information presented quarterly is also available on our website www.panoroenergy.com. Pursuant to the Norwegian Public Limited Liability Companies Act (

SCANDION ONCOLOGY ANNOUNCES OUTCOME IN THE RIGHTS ISSUE

Scandion Oncology A/S (“Scandion” or the “Company”) announces that the result of its rights issue (the “Rights Issue”), where the subscription period ended on December 10, 2020, shows that 3,600,363 shares, corresponding to approximately 34 percent of the shares offered, were subscribed for by exercise of subscription rights. Additionally, 1,634,048 shares, corresponding to approximately 15 percent of the Right Issue, were subscribed for without use of subscription rights, of which 1,318,505 shares, corresponding to 12 percent of the Rights Issue, were subscribed for by external professional

Nobina completes strategic acquisition of KE'S Bussar and strengthens its position in western Sweden

Nobina has entered an agreement to acquire the bus company Karl Erik Elofsson Buss Aktiebolag, domiciled in Kungsbacka, western Sweden. The acquisition strengthens Nobina’s position in western Sweden and broadens its contract portfolio, at the same time as there are new synergies between existing contracts, forthcoming tenders and bus-for-rail services. The acquisition encompasses a business with approximately 100 buses and 100 employees in tendered regular services and school bus services in addition to coach hire and bus-for-rail services. The transaction represents a continuation of Nobina’

Invitation to listing ceremony

Tomorrow, the 16[th] of December 2020, is the first day of trading in Cessatech A/S ("Cessatech" or the “Company”) shares and warrants of series TO 1 on Spotlight Stock Market and the Company hereby welcomes shareholders to join the listing ceremony. Participants are asked to register with Eventbrite using the following link:https://www.eventbrite.com/e/cessatechs-virtual-listing-ceremony-tickets-132301905561Prior to the listing, Cessatech conducted a successful IPO of units which provided the Company with approx. DKK 15.8 million (before issue costs) and approx. 1,270 new shareholders.

Frame Agreement with ExxonMobil in Brazil

Solstad Offshore ASA is pleased to announce that the company has entered into a Frame Agreement with ExxonMobil Exploração Brasil Ltda for the provision of supply vessel services supporting their exploration activities in Brazil. The Frame Agreement is for 3 years firm, and the first call off has been received for PSV “Normand Swift” for a period of 3 months with commencement during December. Skudeneshavn, December 15[th], 2020 ContactsLars Peder Solstad CEO, at +47 91 31 85 85Kjetil Ramstad CFO, at +47 90 75 94 89 Solstad Offshore ASAwww.solstad.com

VibroSense Dynamics AB (publ) – Diabetes Foot Screening application approved in ongoing validation study and ready for market launch

VibroSense Dynamics AB (VibroSense) clinical validation study for the new application Diabetes Foot Screening, shows that the company's product VibroSense Meter® II meets all essential criteria for approval according to the clinical validation plan. VibroSense thus keeps the schedule the company has previously communicated and is ready to launch the Diabetes Foot Screening application to both primary and specialist care.During the fall of 2020, VibroSense Dynamics AB has conducted a clinical validation study with the new application Diabetes Foot Screening, designed for the company's

Name and distinct packaging decided for Veg of Lund’s plant-based milk product

Veg of Lund will broaden its range of plant-based food during the first half of 2021. The Swedish company will then introduce its own potato milk, developed by the company in three different versions under the DUG[®] brand. Consumers in England and Sweden will be the first to taste the genius beverage with a brand associated with how its origin was dug up.During spring, Veg of Lund’s range of plant-based beverages will be expanded to include potato milk under the brand DUG[®], a beverage that will satisfy high consumer demands with regard to taste, texture and sustainability. The beverage

Elisa Erkkilä appointed to Neles Executive Team

Neles Corporation, Stock exchange release on December 15, 2020 at 9.30 a.m. EETElisa Erkkilä, LL.M, has been appointed as a member of the Neles Executive Team as of January 1, 2021. Elisa Erkkilä has been with Neles as General Counsel and Chief Compliance Officer since the launch of Neles Corporation in July 2020. Elisa Erkkilä has previously held legal and management positions both in Finland and abroad. Most recently, she served as VP of Compliance and Risk Management at Metso Corporation. NELES CORPORATION Olli Isotalo President and CEO For further information, please

Commencement of a new plan period within the share-based long-term incentive scheme of Neles Corporation

Neles Corporation, Stock exchange release on December 15, 2020 at 9.25 EETThe Board of Directors of Neles Corporation has decided on the commencement of a new plan period within the share-based long-term incentive scheme targeted to Neles’ management and key employees. The scheme comprises a Performance Share Plan (also "PSP") for the top management, a deferred share unit plan (also "DSUP") for other management and selected key employees and a Restricted Share Plan (also "RSP") as a complementary structure for specific situations. Neles originally announced the establishment of the long-

Divio signs Kendris AG the Swiss largest independent multi-family office as a new customer

Divio Technologies AB (publ) is proud to welcome the Swiss financial service provider Kendris AG as a new customer. Kendris is headquartered in Zürich Switzerland and is active in more than 40 countries around the world.Kendris AG offers family office, trust and fiduciary services, Swiss and international tax and legal advice, accounting, outsourcing and art management. The company has acknowledged the benefits of adopting the Divio  platform, in an initial deal that will mean an additional recurring monthly revenue of 3’000 USD during the MVP phase. This phase includes migration of the

Safeture and UK partner SPS sign deal to support insurance market

Safeture AB (publ) today announced it signed a deal with global risk management consultancy Special Projects and Services Limited (SPS) to support the insurance market. The minimum initial contract value for Safeture is 162 000 EUR over the next five years.“It’s great that Safeture is able to work with SPS on this project”, said Magnus Hultman, CEO of Safeture. “We were happy to extend our relationship with SPS in September and this project is a perfect example of how our two companies can pull together to support insurance customers. We look forward to further develop our partnership

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 119 - 15 DECEMBER 2020 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 90. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information: Martin Badsted, CFO, tel.: +45 3315 0451

Neles' financial information and Annual General Meeting in 2021

Neles Corporation, Stock exchange release on December 15, 2020 at 9.15 a.m. EETNeles Corporation will publish the following financial information in 2021: · Financial Statements Review for 2020 on February 3, 2021. Silent period starts on January 4, 2021. · Financial Statements for 2020 during the week of March 1, 2021 at the latest · Interim Review for January-March 2021 on April 27, 2021. Silent period starts on March 28, 2021. · Half-Year Review for January-June 2021 on July 23, 2021. Silent period starts on June 23, 2021. · Interim Review for January-September 2021 on

There are no items matching the current filter
There are no more items matching the current filter
Back to top